Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
AssigneeMetaproteomics, LLC
InventorsJohn G. Babish, Terrence M. Howell, Linda M. Pacioretty
Life of this patent
Estimating the term…
Abstract
A novel formulation is provided that serves to inhibit the inflammatory response in animals. The formulation comprises, as a first component an effective amount of a curcuminoid species and an effective amount of a second component selected from the group consisting of an alpha-acid species or a beta-acid species or derivatives thereof. The composition provides synergistic anti-inflammatory effects in response to physical or chemical injury or abnormal immune stimulation due to a biological agent or unknown etiology.
Claims6
A method of treating diabetes, comprising administering to an individual having diabetes a composition comprising a curcuminoid and a component selected from the group consisting of tetrahydroisohumulone and dihydro-isohumulone.
Dependencies are inferred from the claim text.